Chronic PPI Exposure Tied to Hyperparathyroidism in Elderly

(HealthDay News) — Chronic proton pump inhibitor (PPI) exposure is associated with mild hyperparathyroidism in elderly adults, according to a study published in the October issue of the Journal of the American Geriatrics Society.

Andrew M. Hinson, M.D., from the University of Arkansas for Medical Sciences in Little Rock, and colleagues examined the effect of PPIs with and without concurrent bisphosphonates (BPs) on parathyroid hormone (PTH), vitamin D, and calcium in a retrospective chart review of individuals aged 60 years and older. Data were included for 80 individuals meeting inclusion criteria.